Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany-A Brief Narrative Review
- PMID: 33525323
- PMCID: PMC7931038
- DOI: 10.3390/ijns7010007
Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany-A Brief Narrative Review
Abstract
Sickle cell disease (SCD) is a severe non-malignant disorder of hemoglobin and is inherited in an autosomal-recessive manner [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.Ann Hematol. 2016 Feb;95(3):397-402. doi: 10.1007/s00277-015-2573-y. Epub 2015 Dec 12. Ann Hematol. 2016. PMID: 26658910
-
Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.Ann Hematol. 2019 Jan;98(1):47-53. doi: 10.1007/s00277-018-3477-4. Epub 2018 Aug 21. Ann Hematol. 2019. PMID: 30132072 Clinical Trial.
-
Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.Can J Anaesth. 2013 Jan;60(1):54-9. doi: 10.1007/s12630-012-9807-4. Epub 2012 Oct 27. Can J Anaesth. 2013. PMID: 23104576
-
Sickle cell disease: current activities, public health implications, and future directions.J Womens Health (Larchmt). 2007 Jun;16(5):575-82. doi: 10.1089/jwh.2007.CDC4. J Womens Health (Larchmt). 2007. PMID: 17627395 Review.
-
Newborn Screening for Sickle Cell Disease: Indian Experience.Int J Neonatal Screen. 2018 Nov 13;4(4):31. doi: 10.3390/ijns4040031. eCollection 2018 Dec. Int J Neonatal Screen. 2018. PMID: 33072952 Free PMC article. Review.
Cited by
-
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.Sci Rep. 2022 Jun 13;12(1):9762. doi: 10.1038/s41598-022-13751-8. Sci Rep. 2022. PMID: 35697769 Free PMC article.
-
Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.BMJ Open. 2022 Mar 9;12(3):e057623. doi: 10.1136/bmjopen-2021-057623. BMJ Open. 2022. PMID: 35264367 Free PMC article.
-
Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany.Pharmacoecon Open. 2025 Mar;9(2):291-300. doi: 10.1007/s41669-024-00550-2. Epub 2025 Jan 3. Pharmacoecon Open. 2025. PMID: 39753835 Free PMC article.
-
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038. Int J Neonatal Screen. 2024. PMID: 38920845 Free PMC article. Review.
-
Newborn Screening for Sickle Cell Disease: Results from a Pilot Study in the Portuguese Population.Int J Neonatal Screen. 2025 Jan 27;11(1):10. doi: 10.3390/ijns11010010. Int J Neonatal Screen. 2025. PMID: 39982344 Free PMC article.
References
-
- Kinder-Richtlinie: Screening auf Sichelzellkrankheit bei Neugeborenen. [(accessed on 30 December 2020)]; Available online: https://www.g-ba.de/beschluesse/4560/
-
- Lobitz S., Telfer P., Cela E., Allaf B., Angastiniotis M., Johansson C.B., Badens C., Bento C., Bouva M.J., Canatan D., et al. Newborn screening for sickle cell disease in Europe: Recommendations from a Pan-European Consensus Conference. Br. J. Haematol. 2018;183:648–660. doi: 10.1111/bjh.15600. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources